In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple...

Area of Science:

• Neuroimmunology
• Genomics
• Biomarker Discovery

Background:

• Multiple sclerosis (MS) is a central nervous system inflammatory disease.
• Relapsing-remitting MS (RRMS) often progresses to secondary progressive MS (SPMS) without clear predictive biomarkers.
• Identifying biomarkers for the RRMS to SPMS transition is crucial for patient management.

Purpose of the Study:

• To identify blood-based biomarkers specific to the transition from RRMS to SPMS.
• To find differentially expressed genes (DEGs) common to both blood and brain tissues in SPMS patients.
• To elucidate biological pathways associated with MS progression.

Main Methods:

• Analysis of six datasets comparing SPMS and RRMS patient blood and brain tissues.
• Identification and comparison of DEGs between disease states and tissue types.
• Network analysis of identified DEGs to evaluate their interactions and biological relevance.

Main Results:

• Identified 38 DEGs upregulated in both blood and brain tissues from SPMS patients compared to RRMS patients.
• Network analysis suggested 21 of these DEGs are potentially involved in the SPMS transition.
• Highlighted the calcineurin-NFAT pathway as potentially significant in the RRMS to SPMS progression.

Conclusions:

• The identified DEGs, detectable in blood, show promise as biomarkers for monitoring the elusive MS progression from RRMS to SPMS.
• This blood-based approach could offer a rapid and convenient method for assessing MS status.
• Further validation of these DEGs may facilitate earlier interventions and improved patient care in MS.